CareDx Inc (NASDAQ: CDNA) is a transplant medicine company that provides surveillance and diagnostic solutions for organ transplant recipients and transplant centers. The provided filing excerpts do not contain sufficient detail to describe CareDx's revenue model, segment breakdown, product portfolio, competitive position, geographic footprint, leadership, or founding history with the specificity required by these writing rules. All fields below reflect only what the 10-K filing excerpt (accession 000121723426000018, filed 2026-02-25) directly supports. The excerpt provided is limited to the SEC cover page boilerplate and does not include the business description, financial statements, or management discussion sections needed to produce a grounded company summary.

Source: SEC 10-K, filed 2026-02-25

Industry: Services-Medical Laboratories Peers: Cogent Biosciences Inc Design Therapeutics Inc Editas Medicine Inc Erasca Inc Forma Therapeutics Holdings, Inc. Geron Corp Keros Therapeutics Inc Kura Oncology Inc POINT Biopharma Global Inc.